- Filed
- Aug 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jul 30, 2025 | 3.12M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 3.12M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 3.12M sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 3.03M sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 3.03M sh |
| Capex | Q3 2025 · Mar 31, 2025 | $207.75K |
| Capex | Q3 2025 · Mar 31, 2024 | $723.26K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$5.23M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$6.06M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $1.26M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $4.14M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $19.09M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $21.05M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $23.56M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $25.65M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $30.93M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $34.49M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $37.29M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $39.77M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $9.48M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $14.13M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $10.02M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $15.33M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $9.04M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $18.82M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $29.11M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $40.98M |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$0.63 |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$2.13 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | −$1.20 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | −$2.98 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$0.63 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$2.13 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | −$1.20 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | −$2.98 |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $1.37M |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $3.91M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $1.2M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $4.55M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$1.97M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$6.64M |
| Net Income | Q3 2025 · Dec 31, 2024 | −$2.54M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$2.13M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$3.63M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$9.04M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$2.87M |
| Net Income | Q3 2025 · Sep 30, 2023 | −$2.54M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$1.97M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$6.65M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$3.7M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$9.27M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $3.12M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $8.48M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $4.08M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $12.13M |
| Revenue | Q3 2025 · Mar 31, 2025 | $4.05M |
| Revenue | Q3 2025 · Mar 31, 2025 | $11.91M |
| Revenue | Q3 2025 · Mar 31, 2024 | $5.26M |
| Revenue | Q3 2025 · Mar 31, 2024 | $18.12M |